Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.

Magali RouyerStéphane OudardFlorence JolyKarim FizaziFlorence TubachJérémy JoveClémentine LacueilleStéphanie LamarqueEstelle GuiardAurélie BalestraCécile Droz-PerroteauAnnie Fourrier-ReglatNicholas Moorenull null

Published in: British journal of cancer (2019)

It was registered with the European Medicines Agency EUPASS registry, available at www.encepp.eu, as EUPAS10391. It has been approved as an ENCEPP SEAL study.

Keyphrases

clinical practice
free survival
squamous cell carcinoma
small cell lung cancer
drug administration